An in-depth look to NEOPHARM CO., LTD. operating, investing, and financing activities

092730 free cash flow for Q3 24 is 2.09 B KRW. For 2023, 092730 free cash flow was 3.41 B KRW and operating cash flow was 23.26 B KRW.